tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

EKF Diagnostics Buys Back Shares, Manages Major Shareholder’s Stake Below 30%

Story Highlights
  • EKF Diagnostics repurchased 639,000 shares into treasury, reducing free-float voting stock.
  • The buyback included shares from Harwood-managed funds to keep director Christopher Mills’ stake below 30%.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EKF Diagnostics Buys Back Shares, Manages Major Shareholder’s Stake Below 30%

Claim 70% Off TipRanks Premium

An announcement from EKF Diagnostics Holdings ( (GB:EKF) ) is now available.

EKF Diagnostics Holdings has repurchased 639,000 ordinary shares at a volume-weighted average price of 24.96p per share, with the shares to be held in treasury, leaving 434,012,112 shares carrying voting rights out of a total issued share capital of 435,383,092. As part of the buyback, the company acquired 189,000 shares from funds managed by Harwood Capital, a move designed to keep Non-Executive Director Christopher Mills’ aggregate indirect beneficial interest at roughly its previous level and below 30% of voting rights, thereby managing ownership concentration and maintaining compliance with UK disclosure and takeover thresholds.

The most recent analyst rating on (GB:EKF) stock is a Hold with a £27.00 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.

Spark’s Take on GB:EKF Stock

According to Spark, TipRanks’ AI Analyst, GB:EKF is a Neutral.

EKF Diagnostics Holdings receives a score of 67, driven by strong financial performance and a positive earnings call. The company’s robust balance sheet and improved profitability are significant strengths. However, technical indicators suggest potential bearish momentum, and the valuation is moderate. The positive outlook from the earnings call, including strategic growth plans and a share buyback program, enhances the overall score.

To see Spark’s full report on GB:EKF stock, click here.

More about EKF Diagnostics Holdings

EKF Diagnostics Holdings plc is an AIM-listed global diagnostics business focused on point-of-care analysers in hematology and diabetes, as well as life sciences services that include specialist manufacture of enzymes and custom products for diagnostic, food and industrial applications. Headquartered in Penarth near Cardiff, the company operates five manufacturing sites across the US and Germany and sells into more than 120 countries worldwide.

Average Trading Volume: 498,170

Technical Sentiment Signal: Strong Sell

Current Market Cap: £110.9M

Learn more about EKF stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1